CARsgen Therapeutics Holdings Limited (HKG:2171)
11.90
-0.16 (-1.33%)
Oct 21, 2026, 2:44 PM HKT
HKG:2171 Market Cap
HKG:2171 has a market cap or net worth of 6.69 billion as of October 20, 2026. It is the 11,055th most valuable company in the world and the 539th biggest in Hong Kong. Its market cap has decreased by 30.25% in one year.
Market Cap
6.69B
Enterprise Value
5.15B
Revenue
157.72M
Global Rank
Country Rank
#539 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since June 18, 2021, HKG:2171's market cap has decreased from 17.02B to 6.69B, a decrease of -60.69%. That is a compound annual growth rate of -16.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 6.69B | -18.93% |
| Dec 31, 2025 | 8.25B | 63.11% |
| Dec 31, 2024 | 5.06B | 35.24% |
| Dec 29, 2023 | 3.74B | -56.36% |
| Dec 30, 2022 | 8.57B | -45.06% |
| Dec 31, 2021 | 15.61B | -8.30% |
| Jun 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Suzhou Ribo Life Science | 8.91B |
| HBM Holdings | 8.64B |
| Nanjing Leads Biolabs | 8.38B |
| CStone Pharmaceuticals | 8.09B |
| Shanghai Haohai Biological Technology | 7.17B |
| Lepu Biopharma | 7.01B |
| Alphamab Oncology | 6.84B |
| Ascletis Pharma | 6.05B |